| 别名 | ;['3-(2,4-Dimethoxyphenyl)-2-butenoic Acid'] |
2,4-二甲氧基-β-甲基肉桂酸
2,4-Dimethoxy-β-methylcinnamic Acid （订货以英文为准）
编号：D155054
CAS号：7706-67-4
分子式：C12H14O4
分子量：222.24
| 产品名称 | 2,4-Dimethoxy-β-methylcinnamic Acid |
| 中文名称 | 2,4-二甲氧基-β-甲基肉桂酸 |
| CAS号 | 7706-67-4 |
| MDL编码 | D155054 |
| 分子式（M.F.） | C12H14O4 |
| 分子量（M.W.） | 222.24 |
| Reaxys-RN | 2050283 |
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 个人防护设备 | dust mask type N95 (US)， Eyeshields， Gloves |
| RTECS | MW5135000 |
| WGK德国 | 3 |
技术规格
| Background: | This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. |
| Applications: | WB, IHC, IF |
| Name of antibody: | FOXO1 (Phospho-Ser256) |
| Immunogen: | Synthetic peptide of human FOXO1 (Phospho-Ser256) |
| Full name: | forkhead box O1 (Phospho-Ser256) |
| Synonyms： | FKH1; FKHR; FOXO1A |
| SwissProt: | Q12778 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 70 kDa |
| WB Positive control: | 293 cells untreated or treated with serum |
| WB Recommended dilution: | 500-1000 |
| IF Positive control: | MCF7 cells |
| IF Recommended dilution | 100-200 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 240.00
jx-612658-1套
¥ 360.00
jx-612659-1台
¥ 947.40
3916-1包
¥ 100.00
sh-355541-1盒
¥ 2280.00
05037891-1台
党沛 
